Filter
8332
Filtered Results: 8332
Text search:
targets
Featured
Recommendations
668
New Publications
2302
Language
Document type
No document type
4776
Studies & Reports
1449
Guidelines
928
Manuals
389
Strategic & Response Plan
340
Fact sheets
158
Training Material
113
Situation Updates
83
Infographics
37
Resource Platforms
32
Brochures
14
Online Courses
10
Dashboards/Maps
3
Countries / Regions
Global
394
India
297
Kenya
270
Ethiopia
189
Uganda
175
Nepal
165
Myanmar / Burma
162
Nigeria
160
South Africa
152
Liberia
144
Western and Central Europe
144
Sierra Leone
143
Indonesia
140
Rwanda
133
Malawi
125
Bangladesh
122
Africa
121
Zambia
120
Latin America and the Carribbean
111
Tanzania
108
Ghana
105
Syria
103
Ukraine
81
Congo, Democratic Republic of
74
Namibia
70
Philippines
69
South Sudan
62
Cambodia
61
South–East Asia Region
59
Zimbabwe
54
Lesotho
52
Asia
51
Senegal
49
Mozambique
49
East and Southern Africa
49
West and Central Africa
48
Eastern Europe
48
Yemen
41
Botswana
39
Middle East and North Africa
38
Guinea
36
Haiti
34
Russia
33
Pakistan
29
Venezuela
29
Burkina Faso
27
Eastern Europe and Central Asia
26
Brazil
24
Colombia
24
Western Pacific Region
24
Cameroon
23
Afghanistan
23
Germany
23
Jordan
21
Sudan
21
Eswatini/ Swaziland
21
Somalia
20
Lebanon
19
Central African Republic
18
Benin
16
Tajikistan
15
Mali
14
Thailand
14
Moldova
14
Vietnam
14
Iraq
12
USA
11
Paraguay
11
Albania
11
Laos
11
Georgia
11
Sri Lanka
10
Palestine
10
Turkey
8
China
8
Southern Africa
8
Kyrgyzstan
8
North America
8
Côte d’Ivoire / Ivory Coast
7
Peru
7
Burundi
7
Libya
7
Angola
7
Madagascar
7
Mexico
7
Iran
7
Kazakhstan
7
North Macedonia
6
Chile
6
Armenia
6
Jamaica
6
Egypt
5
Chad
5
Papua New Guinea
5
Argentina
5
Timor Leste/ East Timor
5
Guinea-Bissau
4
Saudi Arabia
4
Niger
4
Gambia
4
Serbia
4
Ecuador
4
Bolivia
4
Bhutan
4
Poland
4
Uzbekistan
4
Turkmenistan
4
United Kingdom
4
Singapore
3
Hungary
3
El Salvador
3
Greece
3
Guatemala
3
Romania
3
Portugal
3
Spain
3
Belarus
3
Bosnia and Herzegovina
3
Morocco
2
Togo
2
Malaysia
2
Mauritania
2
Croatia
2
Fiji
2
Djibouti
2
Canada
2
Qatar
2
Bulgaria
2
Estonia
2
Japan
2
Belgium
2
Mauritius
2
Azerbaijan
2
Ireland
1
Vanuatu
1
Dominican Republic
1
Honduras
1
Bahamas
1
Other region
1
North Korea
1
Italy
1
Congo-Brazzaville
1
Lithuania
1
Slovakia
1
Gabon
1
Denmark
1
Maldives
1
Tunisia
1
Norway
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
3256
Clinical Guidelines
571
Public Health
488
Women & Child Health
397
Key Resources
393
Capacity Building
143
Pharmacy & Technologies
78
Annual Report MEDBOX
3
Toolboxes
HIV
720
COVID-19
624
Mental Health
557
TB
428
Planetary Health
348
Disability
300
Conflict
261
AMR
246
NTDs
218
Rapid Response
213
NCDs
197
Caregiver
183
Ebola
175
Global Health Education
152
Refugee
134
Natural Hazards
111
Health Financing Toolbox
109
Pharmacy
97
Polio
51
Cholera
50
Zika
47
Specific Hazards
44
Social Ethics
18
Typhoon
6
South Sudan
2
Health Financing
2
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
These guidelines have been compiled for education ministries or other educational leaders (including development partners, non-governmental or private organizations working with schools or directly with caregivers) who want to adapt and adopt resources to support the marginalized caregivers of child...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Breast cancer is the most common cancer worldwide and the leading cause of cancer deaths among women, disproportionately affecting low- and middle-income countries. The Global Breast Cancer Initiative strives to reduce breast cancer mortality by 2.5 percent per year, which over a 20-year period can ...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
FIND and Standard Diagnostics (SD) have developed a lateral flow rapid diagnostic test (RDT) to screen for
T.b. gambiense HAT that is cheap and easy to use. The tests are packed individually and are stable at 40°C for
up to 25 months; they are performed on fresh blood obtained from a finger prick...
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primar...
Cholera is a diarrheal disease caused by the bacterium Vibrio cholera. The infection primarily spreads through contaminated water and food. Symptoms include the onset of acute diarrhea and/or vomiting, muscle cramps, and body weakness. If untreated, the infection can result in rapid dehydration and ...
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
Leptospirosis is a zoonotic disease with epidemic potential, especially after a heavy rainfall,
caused by a bacterium called Leptospira. Leptospira interrogans is pathogenic to humans and
animals, with more than 200 serologic variants or serovars. Humans usually acquire
leptospirosis through dire...
Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as an important cause of pulmonary haemorrhage syndrom...
